Steering and funding

Funding

The SciLifeLab national infrastructure is financed through grants from the Swedish government, including distinct funding for our Drug Discovery and Development platform. In addition, we also receive governmental funding through our host universities within the scope of Strategic Research Areas (SFO). 

Read more about the Swedish government’s efforts to strengthen life science:

SciLifeLab management

Management Group

Integration Directors

Operations Office

Boards and committees

The SciLifeLab Board

The SciLifeLab Board started its assignment during spring 2013, in accordance with directives from the Swedish government. The Board includes one representative each from the four host universities, three representatives from other Swedish universities, one representative from the industry, and is led by chairman Carl-Henrik Heldin, appointed by the Swedish Government. The Board is responsible for the national infrastructure, the management and the communication of SciLifeLab.

• Carl-Henrik Heldin, Government appointed Chair, Director of the Ludwig Institute in Uppsala, Professor in Molecular Cell Biology at Uppsala University and chair of the Board of the Nobel Foundation
• Lotta Ljungqvist, CEO, Testa Center, Cytiva, Government appointed Industry representative
• Annika Stensson Trigell, Professor, KTH Royal Institute of Technology
• Stellan Sandler, Professor, Uppsala University
• Anders Karlhede, Deputy Vice President, Stockholm University
• Anders Gustafsson, Acting Deputy Vice President, Karolinska Institutet
• Fredrik Elinder, Prodean of Faculty of Medicine and Health, Linköping University
• Göran Landberg, Deputy Vice-Chancellor, Gothenburg University
• Katrine Riklund, Pro-vice-chancellor, Umeå University
• Gunilla Westergren-Thorsson, National SciLifeLab Committee Chair, Lund University, Co-opted member

International Advisory Board

• Jan Ellenberg, Chair (EMBL Heidelberg, Germany)
• Sören Brunak (Technical University of Denmark, Denmark)
• Jo Bury (VIB, Belgium)
• Yoshihide Hayashizaki (RIKEN Omics Science Center, Japan)
• Sirpa Jalkanen (University of Turku, Finland)
• Janet Jansson (Pacific Northwest National Laboratory, USA)
• Jonathan Knowles (FIMM, University of Helsinki, Finland)
• Svante Pääbo (Max Planck Institute for Evolutionary Anthropology, Germany)
• Aviv Regev (Broad Institute, MIT, USA)
• Sarah Teichmann (EMBL-EBI & Wellcome Sanger Institute, UK)

More information: International Advisory Board – Member biographies.

National SciLifeLab Committee

• Gunilla Westergren-Thorsson, chair (SciLifeLab Board)
• Maria Fällman (Umeå University)
• Martin Olsson (Lund University)
• Jan Stenlid (Swedish University of Agricultural Sciences)
• Carina Mallard (University of Gothenburg)
• Maria Jenmalm (Linköping University)
• Tommy Olsson (Umeå University/WCMM)

SciLifeLab committees at host universities

SciLifeLab committee Karolinska Institutet

• Stefan Eriksson, Chair
• Janne Lehtiö
• Lars Engstrand
• Katja Petzold
• Anna Falk
• One member representing SciLifeLab Fellows

SciLifeLab committee KTH Royal Institute of Technology
Link to meeting minutes

• Amelie Eriksson Karlström
• Peter Nilsson
• Sophia Hober
• Afshin Ahmadian
• Hjalmar Brismar
• Lucie Delamotte
• Kevin Smith
• Annika Stensson Trigell
• Mathias Uhlén
• Fredrik Sterky

SciLifeLab committee Stockholm University

• Henrik Cederquist
• Ylva Engström
• Barbara Wohlfarth
• Lennart Bergström
• Tom Britton
• Sören Nylin
• Joakim Edsjö
• Katariina Kiviniemi Birgersson
• Jesper Norell
• Yuan Guo

SciLifeLab committee Uppsala University

• Jenny Alfredsson
• Anna Dimberg
• Titti Ekegren
• Margareta Hammarlund-Udenaes
• Peter Lindblad
• Karl Michaelson
• Aris Moustakas
• Mia Phillipson
• Anna Qvarnström
• Anna Rosling
• Staffan Svärd
• Eva Tiensuu Janson
• Carolina Wählby

International Evaluation Committee

• Geert Van Minnebruggen, Chair (Head of VIB Core Facilities, Head of VIB Science & Technology Unit, VIB, Belgium)
• Janna Saarela, Co-chair (Professor of Medicine at University of Oslo, Director of the Centre for Molecular Medicine Norway (NCMM), Norway)
• Ellen Berg (Chief Scientific Officer, Translational Biology at Eurofins Discovery, US)
• Justin Bryans (Executive Director, Drug Discovery at LifeArc, UK)
• Rainer Pepperkok (Director of Scientific Core Facilities and Scientific Services, European Molecular Biology Laboratory (EMBL), Germany)
• Michael Sattler (Professor of Biomolecular NMR, Dept of Chemistry, Technical University of Munich, Head of Institute of Structural Biology, Helmholtz Center Munich, Germany)
• Hanno Steen (Associate Professor of Pathology at Harvard Medical School, Director of Proteomics at Boston Children’s Hospital, US)
• Riitta Lahesmaa (Academy Professor, Director of Turku Bioscience Centre, University of Turku | Co-Director of BioCity Turku Centre for Life Span Research, Finland)
• Rolf Apweiler (Director of European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI) United Kingdom)

Organization and management of infrastructure

Platforms and facilities

SciLifeLab offers advanced technologies, knowhow and support to researchers in Sweden. These technologies and services are provided by facilities, which each represent a certain area of expertise. The facilities are organized into platforms that represent areas of research where a combination of technologies is generally used. Each platform has a Platform Advisory Board responsible for the service offering, strategic decisions and priority management. You can read more about the steering of the national infrastructure in the document to the right (in Swedish and English).

SciLifeLab has ten national platforms, each offering technologies and services through one to eight facilities. Researchers from all over Sweden can apply for technologies and service using the national platforms. Pricing may differ between different facilities, but in general a cost-of-reagents pricing is used.

Each platform is managed by a Platform Director with a Vice Platform Director when applicable who take part in the Platform Advisory Board meetings.

Each facility is managed by a Facility Director and a Head of Facility. The Facility Director ensures the scientific leadership of the platform. The Head of Facility is responsible for the every day operation of the facility.